Berman Capital Advisors, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,000
+50.0%
239
+9.6%
0.00%
Q2 2021$2,000
+100.0%
218
+69.0%
0.00%
Q1 2021$1,0000.0%1290.0%0.00%
Q4 2020$1,0000.0%129
-39.4%
0.00%
Q3 2020$1,000213
+153.6%
0.00%
Q2 2020$0
-100.0%
84
-30.0%
0.00%
Q1 2020$1,0000.0%1200.0%0.00%
Q4 2019$1,0000.0%1200.0%0.00%
Q3 2019$1,0000.0%1200.0%0.00%
Q2 2019$1,0000.0%1200.0%0.00%
Q1 2019$1,0000.0%1200.0%0.00%
Q4 2018$1,0001200.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders